来凯医药-B(02105)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

02105 来凯医药-B

已收盘 07-11 16:08:03

16.600

+0.220

+1.34%

最高17.300	最低16.300	成交量452.03万
今开16.600	昨收16.380	日振幅6.11%
总市值67.73亿	流通市值67.73亿	总股本4.08亿
成交额7,624万	换手率1.11%	流通股本4.08亿
市净率7.68	ROE-31.61%	每股收益-0.78
52周最高23.500	52周最低3.900	市盈率-21.32
股息0.00	股息收益率0.00	ROA-19.07%

北京优虎网络科技有限公司

免责声明:香港交易所资讯服务有限公司、其控股公司及／或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度，但不能保证其绝对准确和可靠，且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任（不管是否侵权法下的责任或合约责任又或其它责任）

{"stockData":{"symbol":"02105","market":"HK","secType":"STK","nameCN":"来凯医药-B","latestPrice":16.6,"timestamp":1752221283033,"preClose":16.38,"halted":0,"volume":4520300,"delay":0,"floatShares":408000000,"shares":408000000,"eps":-0.778779394767209,"marketStatus":"已收盘","change":0.22,"latestTime":"07-11 16:08:03","open":16.6,"high":17.3,"low":16.3,"amount":76239923,"amplitude":0.06105,"askPrice":16.62,"askSize":31500,"bidPrice":16.6,"bidSize":5000,"shortable":3,"etf":0,"ttmEps":-0.778779394767209,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1752456600000},"marketStatusCode":5,"adr":0,"listingDate":1687968000000,"exchange":"SEHK","adjPreClose":16.38,"openAndCloseTimeList":[[1752197400000,1752206400000],[1752210000000,1752220800000]],"volumeRatio":1.061553,"lotSize":500,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/02105","defaultTab":"news","newsList":[{"id":"2550280939","title":"每日卖空追踪 | 来凯医药-B 07月11日卖空量成交34.3万股，卖空比例为7.68%","url":"https://stock-news.laohu8.com/highlight/detail?id=2550280939","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2550280939?lang=zh_cn&edition=full","pubTime":"2025-07-11 16:30","pubTimestamp":1752222627,"startTime":"0","endTime":"0","summary":"来凯医药-B北京时间07月11日，涨1.34%，卖空量成交34.3万股%，较上一交易日增加31.42%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250711172444a6a37dc3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250711172444a6a37dc3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","02105"],"gpt_icon":0},{"id":"2550061048","title":"来凯医药-B07月10日获主力加仓997.7万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2550061048","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2550061048?lang=zh_cn&edition=full","pubTime":"2025-07-10 16:15","pubTimestamp":1752135335,"startTime":"0","endTime":"0","summary":"07月10日, 来凯医药-B股价涨7.62%，报收16.38元，成交金额8262.6万元，换手率1.25%，振幅8.94%，量比1.29。来凯医药-B今日主力资金净流入997.7万元，上一交易日主力净流入192.7万元。该股近5个交易日下跌1.80%，主力资金累计净流入900.1万元；近20日主力资金累计净流出3597.9万元，其中净流出天数为8日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250710165448a4422ebf&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250710165448a4422ebf&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","02105"],"gpt_icon":0},{"id":"2550635621","title":"每日卖空追踪 | 来凯医药-B 07月09日卖空量成交10.65万股，卖空比例为2.95%","url":"https://stock-news.laohu8.com/highlight/detail?id=2550635621","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2550635621?lang=zh_cn&edition=full","pubTime":"2025-07-09 16:30","pubTimestamp":1752049828,"startTime":"0","endTime":"0","summary":"来凯医药-B北京时间07月09日，跌4.52%，卖空量成交10.65万股%，较上一交易日减少68.81%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250709172335a44004d2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250709172335a44004d2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","02105"],"gpt_icon":0},{"id":"2549094598","title":"来凯医药-B盘中异动 早盘股价大跌5.06%","url":"https://stock-news.laohu8.com/highlight/detail?id=2549094598","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2549094598?lang=zh_cn&edition=full","pubTime":"2025-07-08 10:31","pubTimestamp":1751941885,"startTime":"0","endTime":"0","summary":"2025年07月08日早盘10时31分，来凯医药-B股票出现异动，股价大幅下挫5.06%。截至发稿，该股报16.140港元/股，成交量100.05万股，换手率0.25%，振幅6.82%。来凯医药-B股票所在的生物技术行业中，整体跌幅为0.09%。其相关个股中，正大企业国际、华康生物医学、基石药业-B涨幅较大，振幅较大的相关个股有基石药业-B、北海康成-B、正大企业国际，振幅分别为18.57%、16.28%、13.95%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250708103125a69c15b6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250708103125a69c15b6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","02105"],"gpt_icon":0},{"id":"2549790587","title":"每日卖空追踪 | 来凯医药-B 07月07日卖空量成交19.9万股，卖空比例为11.13%","url":"https://stock-news.laohu8.com/highlight/detail?id=2549790587","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2549790587?lang=zh_cn&edition=full","pubTime":"2025-07-07 16:30","pubTimestamp":1751877028,"startTime":"0","endTime":"0","summary":"来凯医药-B北京时间07月07日，跌1.85%，卖空量成交19.9万股%，较上一交易日减少53.34%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250707171936a43b8340&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250707171936a43b8340&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","02105"],"gpt_icon":0},{"id":"2548364230","title":"每日卖空追踪 | 来凯医药-B 07月04日卖空量成交32.4万股，卖空比例为7.33%","url":"https://stock-news.laohu8.com/highlight/detail?id=2548364230","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2548364230?lang=zh_cn&edition=full","pubTime":"2025-07-04 16:30","pubTimestamp":1751617829,"startTime":"0","endTime":"0","summary":"来凯医药-B北京时间07月04日，涨3.84%，卖空量成交32.4万股%，较上一交易日增加356.34%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250704172200a72e88f5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250704172200a72e88f5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","02105"],"gpt_icon":0},{"id":"2548361379","title":"来凯医药-B07月04日主力净流入75.6万元 散户资金抛售","url":"https://stock-news.laohu8.com/highlight/detail?id=2548361379","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2548361379?lang=zh_cn&edition=full","pubTime":"2025-07-04 16:15","pubTimestamp":1751616912,"startTime":"0","endTime":"0","summary":"07月04日, 来凯医药-B股价涨3.84%，报收17.32元，成交金额7597.8万元，换手率1.09%，振幅7.91%，量比1.06。来凯医药-B今日主力资金净流入75.6万元，上一交易日主力净流出618.9万元。该股近5个交易日下跌1.14%，主力资金累计净流入133.3万元，其中1个交易日为股价上涨时净流出；近20日主力资金累计净流出4174.7万元，其中净流出天数为8日。该股主力净额占比0.01%，港股市场排名295/2666。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250704165345a72e77aa&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250704165345a72e77aa&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","02105"],"gpt_icon":0},{"id":"2548071354","title":"中信建投：全球市场极具吸引力 中国创新药全球化产业趋势明确","url":"https://stock-news.laohu8.com/highlight/detail?id=2548071354","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2548071354?lang=zh_cn&edition=full","pubTime":"2025-07-04 14:35","pubTimestamp":1751610910,"startTime":"0","endTime":"0","summary":"中信建投发布研报称，中国诸多创新药资产近年来逐步进入全球视野，临床数据在各类学术会议上占据越发重要的地位，BD授权金额及数量持续攀升，全球影响力持续扩大。随着中国创新药竞争力持续提升及被发现，将有更多BD交易达成，一批授出项目有望在未来2-3年看到在全球主要市场陆续上市，带动国内创新药企迎来全球化发展加速。全球市场极具吸引力，中国创新药全球化产业趋势明确创新药海外市场规模占据主要地位。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025070414363895362703&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025070414363895362703&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["601066","159992","02162","LU1064130708.USD","LU2148510915.USD","BK0239","LU1064131003.USD","BK0276","06160","02105","LU2488822045.USD","688331"],"gpt_icon":0},{"id":"2548335373","title":"港股异动 | 来凯医药-B(02105)再涨超4% 就LAE103向美国FDA递交新药临床试验申请","url":"https://stock-news.laohu8.com/highlight/detail?id=2548335373","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2548335373?lang=zh_cn&edition=full","pubTime":"2025-07-04 11:51","pubTimestamp":1751601098,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，来凯医药-B再涨超4%，截至发稿，涨4.2%，报17.38港元，成交额4544.15万港元。消息面上，来凯医药近日公布，集团已就自主研发的LAE103，向美国食品药品监督管理局递交新药临床试验申请，潜在用于治疗肌少性肥胖症及肌肉相关疾病患者。LAE102的中国I期MAD研究已启动，评估皮下给药LAE102在60名超重/肥胖受试者中的安全性、耐受性、PD和PK，预计25Q3数据读出。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1313917.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1161","BK1141","02105","BK1576","BK1583","03347"],"gpt_icon":0},{"id":"2548386799","title":"每日卖空追踪 | 来凯医药-B 07月02日卖空量成交6500股，卖空比例为0.12%","url":"https://stock-news.laohu8.com/highlight/detail?id=2548386799","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2548386799?lang=zh_cn&edition=full","pubTime":"2025-07-02 16:30","pubTimestamp":1751445029,"startTime":"0","endTime":"0","summary":"来凯医药-B北京时间07月02日，跌7.1%，卖空量成交6500股%，较上一交易日减少96.17%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250702172059a72a490b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250702172059a72a490b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02105","BK1161"],"gpt_icon":0},{"id":"2548837736","title":"来凯医药-B盘中异动 股价大涨5.27%","url":"https://stock-news.laohu8.com/highlight/detail?id=2548837736","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2548837736?lang=zh_cn&edition=full","pubTime":"2025-07-02 09:30","pubTimestamp":1751419820,"startTime":"0","endTime":"0","summary":"2025年07月02日早盘09时30分，来凯医药-B股票出现异动，股价大幅上涨5.27%。截至发稿，该股报18.380港元/股，成交量2.7万股，换手率0.01%，振幅4.01%。来凯医药-B股票所在的生物技术行业中，整体涨幅为0.93%。其相关个股中，科笛-B、加科思-B、北海康成-B涨幅较大，振幅较大的相关个股有加科思-B、来凯医药-B、北海康成-B，振幅分别为4.15%、4.01%、3.45%。LAE001是雄性激素合成抑制剂,可同时抑制CYP17A1及CYP11B2。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250702093020a4c9f3d5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250702093020a4c9f3d5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02105","BK1161"],"gpt_icon":0},{"id":"2547062468","title":"每日卖空追踪 | 来凯医药-B 06月30日卖空量成交5.65万股，卖空比例为1.1%","url":"https://stock-news.laohu8.com/highlight/detail?id=2547062468","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2547062468?lang=zh_cn&edition=full","pubTime":"2025-06-30 16:30","pubTimestamp":1751272225,"startTime":"0","endTime":"0","summary":"来凯医药-B北京时间06月30日，跌3%，卖空量成交5.65万股%，较上一交易日减少69.95%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250630171858a4c64108&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250630171858a4c64108&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","02105"],"gpt_icon":0},{"id":"2547345650","title":"来凯医药-B盘中异动 大幅下挫5.00%报17.100港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2547345650","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2547345650?lang=zh_cn&edition=full","pubTime":"2025-06-30 09:42","pubTimestamp":1751247733,"startTime":"0","endTime":"0","summary":"2025年06月30日早盘09时42分，来凯医药-B股票出现波动，股价快速下挫5.00%。截至发稿，该股报17.100港元/股，成交量33.5万股，换手率0.08%，振幅5.11%。机构评级方面，在所有3家参与评级的机构中，100%的券商给予买入建议，无券商给予持有、卖出建议。来凯医药-B股票所在的生物技术行业中，整体跌幅为0.18%。LAE001是雄性激素合成抑制剂,可同时抑制CYP17A1及CYP11B2。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250630094213a724e248&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250630094213a724e248&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","02105"],"gpt_icon":0},{"id":"2547365990","title":"来凯医药-B(02105)：就LAE103向FDA递交IND申请","url":"https://stock-news.laohu8.com/highlight/detail?id=2547365990","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2547365990?lang=zh_cn&edition=full","pubTime":"2025-06-30 08:40","pubTimestamp":1751244044,"startTime":"0","endTime":"0","summary":"智通财经APP讯，来凯医药-B(02105)发布公告，集团已就自主研发的LAE103(一种针对ActRIIB的单克隆抗体)，向美国食品药品监督管理局(FDA)递交了新药临床试验申请，潜在用于治疗肌少性肥胖症及肌肉相关疾病患者。公司将与监管机构密切合作，完成申请流程，并致力于为需要新型治疗方案的代谢疾病患者提供这种精准治疗。集团计画分别评估靶向ActRIIA与ActRIIB受体的单克隆抗体在人体中的疗效及安全性。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1311502.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1161","02105"],"gpt_icon":0},{"id":"2547033197","title":"港股概念追踪 | 首款国产GLP-1双靶点减肥药获批上市 国内多家药企布局减肥药赛道(附概念股)","url":"https://stock-news.laohu8.com/highlight/detail?id=2547033197","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2547033197?lang=zh_cn&edition=full","pubTime":"2025-06-30 07:23","pubTimestamp":1751239421,"startTime":"0","endTime":"0","summary":"据悉，中国已获批了四款GLP-1减肥药上市，分别是利拉鲁肽、贝那鲁肽、司美格鲁肽及替尔泊肽，前两款药物属于短效制剂，生产厂家是国产企业；后两款是长效制剂，为进口药物。恒瑞医药的GLP-1/GIP双靶点药物HRS-7535在Ⅲ期临床试验中取得了显著的减重效果，减重效果达18%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1311461.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1589","BK1515","HSTECH","LU1969619763.USD","GLP","LU2328871848.SGD","LU2488822045.USD","BK1574","YANG","BK4614","BK1161","HSCEI","02105","BK1583","01801","BK4144","01672","BK4590"],"gpt_icon":1},{"id":"2546971175","title":"每日卖空追踪 | 来凯医药-B 06月27日卖空量成交7.4万股，卖空比例为2.01%","url":"https://stock-news.laohu8.com/highlight/detail?id=2546971175","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2546971175?lang=zh_cn&edition=full","pubTime":"2025-06-27 16:30","pubTimestamp":1751013027,"startTime":"0","endTime":"0","summary":"来凯医药-B北京时间06月27日，涨2.74%，卖空量成交7.4万股%，较上一交易日减少45.79%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250627174316a72094b7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250627174316a72094b7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02105","BK1161"],"gpt_icon":0},{"id":"2546854837","title":"每日卖空追踪 | 来凯医药-B 06月26日卖空量成交3.3万股，卖空比例为1.02%","url":"https://stock-news.laohu8.com/highlight/detail?id=2546854837","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2546854837?lang=zh_cn&edition=full","pubTime":"2025-06-26 16:30","pubTimestamp":1750926626,"startTime":"0","endTime":"0","summary":"来凯医药-B北京时间06月26日，跌2.12%，卖空量成交3.3万股%，较上一交易日减少22.35%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250626172401a4bee9bc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250626172401a4bee9bc&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","02105"],"gpt_icon":0},{"id":"2546227035","title":"增肌减脂最强者诞生：礼来Bimagrumab数据惊艳 来凯(02105)LAE102价值上升","url":"https://stock-news.laohu8.com/highlight/detail?id=2546227035","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2546227035?lang=zh_cn&edition=full","pubTime":"2025-06-26 08:40","pubTimestamp":1750898420,"startTime":"0","endTime":"0","summary":"ActRII增肌减脂药物，当前全球范围除Bimagrumab外，仅有来凯医药LAE102处于临床阶段。Bimagrumab、LAE102作为ActRII通路项目，彼此关系是共存大于竞争，互相强化逻辑。LAE102成为BD大热门。Bimagrumab BELIEVE试验共招募约500名参与者，以大样本数据验证ActRII作用机制。在备受关注的安全性方面，Bimagrumab常见不良反应包括肌肉痉挛、腹泻、痤疮。Bimagrumab惊艳的疗效数据，点亮ActRII通路，在ADA年会之后，中国创新资产LAE102的潜在价值更可高看一眼。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1309873.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"增肌减脂最强者诞生：礼来Bimagrumab数据惊艳 来凯(02105)LAE102价值上升","news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU2237443978.SGD","LU2471134523.USD","SG9999001176.SGD","LU0058720904.USD","LU0889565916.HKD","IE00BJJMRZ35.SGD","LU0256863902.USD","LU1551013342.USD","LU2357305700.SGD","02105","IE00BJT1NW94.SGD","LU2237443622.USD","LU2552382215.SGD","LU0354030511.USD","LU2112291526.USD","LU2089984988.USD","LU1868837300.USD","LU0354030438.USD","LU2471134879.HKD","SG9999013999.USD","LU1868837136.USD","LU2237443465.HKD","LU2417539215.USD","LU2237443382.USD","BK4585","LU0109391861.USD","BK4588","LU1064131342.USD","LU1814569148.SGD","LU2265009873.SGD","LU2462157665.USD","SG9999018865.SGD","IE00B4R5TH58.HKD","SG9999014898.SGD","LU0094547139.USD","LU2237443895.HKD","SG9999015986.USD","BK4516","LU1868836591.USD","LU0316494557.USD","LU2237443549.SGD","LU0323591593.USD","LU0417517546.SGD","LU1127390331.HKD","LU0708995401.HKD","LU1366192091.USD","LU2471134796.USD","LU0109394709.USD","IE00BK4W5L77.USD"],"gpt_icon":1},{"id":"2546193842","title":"每日卖空追踪 | 来凯医药-B 06月25日卖空量成交2.1万股，卖空比例为0.26%","url":"https://stock-news.laohu8.com/highlight/detail?id=2546193842","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2546193842?lang=zh_cn&edition=full","pubTime":"2025-06-25 16:30","pubTimestamp":1750840225,"startTime":"0","endTime":"0","summary":"来凯医药-B北京时间06月25日，跌9.14%，卖空量成交2.1万股%，较上一交易日减少92.96%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250625175408a4bd1ede&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250625175408a4bd1ede&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","02105"],"gpt_icon":0},{"id":"2546263231","title":"来凯医药-B盘中异动 早盘快速下挫5.08%报18.700港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2546263231","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2546263231?lang=zh_cn&edition=full","pubTime":"2025-06-25 10:13","pubTimestamp":1750817617,"startTime":"0","endTime":"0","summary":"2025年06月25日早盘10时13分，来凯医药-B股票出现异动，股价快速下挫5.08%。截至发稿，该股报18.700港元/股，成交量147.8万股，换手率0.36%，振幅6.60%。资金方面，该股资金流入1184.41万港元，流出1523.19万港元。机构评级方面，在所有3家参与评级的机构中，100%的券商给予买入建议，无券商给予持有、卖出建议。来凯医药-B股票所在的生物技术行业中，整体涨幅为0.57%。LAE001是雄性激素合成抑制剂,可同时抑制CYP17A1及CYP11B2。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250625101337978db7a2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250625101337978db7a2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02105","BK1161"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.laekna.com","stockEarnings":[{"period":"1week","weight":-0.018},{"period":"1month","weight":-0.2588},{"period":"3month","weight":0.5395},{"period":"6month","weight":0.3104},{"period":"1year","weight":2.2181},{"period":"ytd","weight":0.7481}],"compareEarnings":[{"period":"1week","weight":-0.0017},{"period":"1month","weight":-0.0056},{"period":"3month","weight":0.1489},{"period":"6month","weight":0.2604},{"period":"1year","weight":0.3753},{"period":"ytd","weight":0.1978}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"来凯医药有限公司是一家主要从事癌症、肝脏疾病及肥胖症创新疗法的发现、开发及商业化的投资控股公司。该公司尚处于研发阶段。该公司的在研管线产品包括Afuresertib（LAE002）、LAE001、LAE109、LAE111、LAE112、LAE113、LAE117、LAE118、LAE119、LAE102、LAE103、LAE104、LAE105、LAE106、LAE107、LAE120、LAE123等。Afuresertib是一种三磷酸腺苷（ATP）竞争性AKT抑制剂。LAE001是雄激素合成抑制剂，可同时抑制CYP17A1及CYP11B2。该公司主要在中国、美国、欧洲、韩国等市场开展业务。","exchange":"SEHK","name":"来凯医药-B","nameEN":"LAEKNA-B"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.34.3","shortVersion":"4.34.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"来凯医药-B(02105)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供来凯医药-B(02105)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"来凯医药-B,02105,来凯医药-B股票,来凯医药-B股票老虎,来凯医药-B股票老虎国际,来凯医药-B行情,来凯医药-B股票行情,来凯医药-B股价,来凯医药-B股市,来凯医药-B股票价格,来凯医药-B股票交易,来凯医药-B股票购买,来凯医药-B股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"来凯医药-B(02105)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供来凯医药-B(02105)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}